BRIEF

on AEVIS VICTORIA SA (isin : CH0478634105)

AEVIS VICTORIA SA Generates Over CHF 450 Million in H1 2024

AEVIS VICTORIA SA (AEVS:SW) reported revenues exceeding CHF 450 million for the first half of 2024, a notable increase compared to CHF 428 million in the same period last year. Consolidated EBITDA is anticipated to grow by more than 25%, reaching between CHF 40 and 45 million.

Both major divisions, Swiss Medical Network and MRH Switzerland AG, contributed to this growth. Swiss Medical Network achieved net revenues exceeding CHF 350 million, driven by restored activities at Clinique de Genolier post-construction of the Genolier Innovation Hub. This division also benefited from cost optimization measures, adding CHF 6 million improvement in margins. MRH Switzerland AG saw revenues near CHF 100 million, with hotels in Davos and Interlaken showing double-digit growth.

AEVIS VICTORIA SA will release its Half-year Report on September 19, 2024.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AEVIS VICTORIA SA news